share_log

HC Wainwright & Co. Downgrades IGM Biosciences to Neutral, Lowers Price Target to $7

Benzinga ·  Dec 7, 2023 11:10

HC Wainwright & Co. analyst Robert Burns downgrades IGM Biosciences (NASDAQ:IGMS) from Buy to Neutral and lowers the price target from $11 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment